Table 2 Results of the test-and-treat model implementation by participant source

Underwent an on-site viral load test, n (%)

95/95 (100)

104/104 (100)

–

Viral load test result, n (%)

 Positive

71/95 (74.7)

85/104 (81.7)

0.536^a

 Negative

23/95 (24.2)

18/104 (17.3)

 Invalid

1/95 (1.1)

1/104 (1.0)

Had cirrhosis, n (%)

8/71 (11.3)

7/85 (8.2)^b

0.522^c

Received DAA-based treatment, n (%)

71/71 (100)

81/85 (95.3)^d

0.126^a

Referred to the state hospital for specialized care, n (%)

0/71 (100)

2/85 (2.4)^e

0.501^a

Received DAA-based treatment on the same day as the viral load test, n (%)

43/71 (60.6)

65/81 (80.2)

0.008^c

Completed treatment, n (%)

61/71 (85.9)

55/81 (67.9)

0.009^c

Reasons of incomplete treatment, n (%)

 Imprisonment

1/10 (10.0)

1/26 (3.6)

0.484^a

 LTFU

9/10 (90.0)

25/26 (96.2)

Had an SVR test result, n (%)

61/61 (100)

54/55 (98.2)

0.474^a

Achieved SVR, n (%)

56/61 (91.8)

50/54 (92.6)

> 0.95^a